Sapient Capital’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $728K | Hold |
200,000
| – | – | 0.01% | 219 |
|
|
2025
Q1 | $384K | Hold |
200,000
| – | – | 0.01% | 264 |
|
|
2024
Q4 | $380K | Hold |
200,000
| – | – | 0.01% | 271 |
|
|
2024
Q3 | $264K | Hold |
200,000
| – | – | 0.01% | 336 |
|
|
2024
Q2 | $204K | Hold |
200,000
| – | – | ﹤0.01% | 349 |
|
|
2024
Q1 | $366K | Hold |
200,000
| – | – | 0.01% | 268 |
|
|
2023
Q4 | $248K | Buy |
+200,000
| New | +$248K | 0.01% | 335 |
|